“Germline GPR161 Mutations Predispose to Pediatric Medulloblastoma”

This article, published in the Journal of Clinical Oncology, reports on a novel gene mutation, GPR161, which predisposes to medulloblastomas. It has been described that this mutation is associated with an increased risk of MB SHH tumors in infants. A click on the following button leads you directly to the article.